The introduction of nicotinamide like a nicotine replacement in e-cigarette and smokeless items represents a big regulatory challenge for your FDA. Nicotinamide does not have nicotinic receptor agonist activity and is known to act as a sedative at superior dosages6. The statements created by Nicotine River, ECBlend, together with other sellers that